BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10021298)

  • 21. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients.
    Matthews CM; Burke TW; Tornos C; Eifel PJ; Atkinson EN; Stringer CA; Morris M; Silva EG
    Gynecol Oncol; 1993 Apr; 49(1):19-23. PubMed ID: 8482554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
    Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early cervical cancer and parametrial involvement: is it significant?
    Steed H; Capstick V; Schepansky A; Honore L; Hiltz M; Faught W
    Gynecol Oncol; 2006 Oct; 103(1):53-7. PubMed ID: 16516279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer.
    Wright JD; Grigsby PW; Rader JS; Mutch DG; Powell MA; Gao F; Gibb RK
    Gynecol Oncol; 2007 Nov; 107(2):280-4. PubMed ID: 17698175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.
    Monk BJ; Wang J; Im S; Stock RJ; Peters WA; Liu PY; Barrett RJ; Berek JS; Souhami L; Grigsby PW; Gordon W; Alberts DS; ; ;
    Gynecol Oncol; 2005 Mar; 96(3):721-8. PubMed ID: 15721417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of survival and adverse events between women with stage IB1 and stage IB2 cervical cancer treated by laparoscopic radical vaginal hysterectomy.
    Hong JH; Choi JS; Lee JH; Son CE; Jeon SW; Bae JW; Eom JM
    Ann Surg Oncol; 2012 Feb; 19(2):605-11. PubMed ID: 21769469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
    Gil-Moreno A; Puig O; Pérez-Benavente MA; Díaz B; Vergés R; De la Torre J; Martínez-Palones JM; Xercavins J
    J Minim Invasive Gynecol; 2005; 12(2):113-20. PubMed ID: 15904613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of bulky stage IB and IA cervical cancer patients treated by radical hysterectomy with and without neoadjuvant chemotherapy: long-term follow-up.
    Manusirivithaya S; Chareoniam V; Pantusart A; Isariyodom P; Srisomboon J
    J Med Assoc Thai; 2001 Nov; 84(11):1550-7. PubMed ID: 11853297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
    Frigerio L; Mariani A; Gandini L; Origoni M; Galli L; Rabaiotti E; Aletti G; Ferrari A
    Int Surg; 1998; 83(3):265-70. PubMed ID: 9870789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial.
    Lahousen M; Haas J; Pickel H; Hackl A; Kurz C; Ogris H; Stummvoll W; Winter R
    Gynecol Oncol; 1999 May; 73(2):196-201. PubMed ID: 10329034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
    Wright JD; Grigsby PW; Brooks R; Powell MA; Gibb RK; Gao F; Rader JS; Mutch DG
    Cancer; 2007 Sep; 110(6):1281-6. PubMed ID: 17654664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis.
    Sevin BU; Lu Y; Bloch DA; Nadji M; Koechli OR; Averette HE
    Cancer; 1996 Oct; 78(7):1438-46. PubMed ID: 8839549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes and prognostic factors of node-negative cervical cancer patients with deep stromal invasion or lymphovascular space involvement following radical hysterectomy.
    Suprasert P; Srisomboon J; Siriaunkgul S; Khunamornpong S; Phongnarisorn C; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Kietpeerakool C
    J Med Assoc Thai; 2006 Sep; 89(9):1368-75. PubMed ID: 17100371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma.
    Kenter GG; Hellebrekers BW; Zwinderman KH; van de Vijver M; Peters LA; Trimbos JB
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):72-6. PubMed ID: 10646820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.